Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions.

Chunmei LiHanfang BiZhenwang FuAo LiNa WanJun HuFan YangTai-Cheng ZhouYupeng LiangWei SuTianpei ShiMei YangRong WangWanting QinXuanjing YuHong-Yi ZhengZumi ZhouYong-Tang ZhengJia WeiGang ZengZijie Zhangnull null

Published in: Communications medicine (2022)

Our results highlight the comparable safety, immunogenicity and cellular immunity memory of CoronaVac in seniors and people living with chronic diseases. This data should reduce vaccine hesitancy in this population.

Keyphrases

sars cov
healthcare
electronic health record
working memory
big data
respiratory syndrome coronavirus
data analysis